Biondvax Universal Flu Vaccine `Well Tolerated'

Bloomberg
Jan. 16, 2012. 11:32 AM EST

Jan. 16 (Bloomberg) -- Tanya Gottlieb, business development manager at Biondvax Pharmaceuticals L... More »

Jan. 16 (Bloomberg) -- Tanya Gottlieb, business development manager at Biondvax Pharmaceuticals Ltd., talks about the development of a universal flu vaccine. She speaks from Tel Aviv with Maryam Nemazee on Bloomberg Television's "The Pulse." « Less

Tags

Biondvax, Universal, Flu, Vaccine, Well, Tolerated, All Media Video, English Multimedia, Interviews, Syndicated AV Repo..., United States, Company News, Health Care, Women in the News, Media Team Europe, Drugs, Israel, Biotechnology, Illness and Disease, Vaccines, Infectious Diseases, AudioVideo, Human Influenza, Bio-tech, Business

Biondvax Universal Flu Vaccine `Well Tolerated'

BloombergJan. 16, 2012. 11:32 AM EST

Bloomberg
Jan. 16, 2012. 11:32 AM EST